Evoke Pharma, Inc. (EVOK) Social Stream

Evoke Pharma, Inc. (EVOK): $1.11

-0.03 (-2.63%)

POWR Rating

Component Grades













Featured Post From StockTwits About EVOK

$EVOK it's almost as if the market is tired of the fake pumps now over the years, as long as there's any substantial news that shows any potential for a large market for the one hit wonder or a buyout, the more they try to pump it the lower it will go
5656l7, published July 26, 2021

What Else are EVOK Traders Talking About?

Other tickers frequently mentioned alongside EVOK is EVOL.

Other Notable StockTweets About EVOK


Finally some help. gla

Item 8.01. Other Events.

On July 14, 2021, Evoke Pharma, Inc. (?Evoke? or the ?Company?), announced the start of additional marketing initiatives focusing on the launch of a patient and physician experience program for GIMOTI?, the Company?s nasal spray product for the relief of symptoms in acute and recurrent diabetic gastroparesis.

The program will provide samples of GIMOTI primarily to targeted gastroenterologists and advance practice practitioners. The program intends to expand awareness and trial of GIMOTI for both physicians and patients and help both groups gain experience with GIMOTI and its non-oral treatment benefits.

tste9, published July 14, 2021

$evlo $evoj $evok $EVOL
Check out ticker COWI, a new power source, this Co will use microwave-initiated CATALYTIC dehydrogenation to turn plastics into hydrogen, coroware.com on June 2nd COROWARE entered into a license agreement with Oxford University Innovation Limited, (the licensor) Under the terms of the agreement, the licensee will license the Licensed technology,
(OUI Project-Hydrogen from plastics via Microwave Initiated
Catalytic dehydrogenation)
The Global Hydrogen market is expected to be double by the end of the decade! Plastic waste is a cheap and abundant feedstock that will allow the Co to scale quickly and produce hydrogen gas at a competitive price! Plastic to power!

Dragonman1, published July 13, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.5193 seconds.